GPR55 and metabolic disease: Intriguingly, we found that total and visceral fat mass are associated with elevated levels of lipid mediators known to activate a wide range of receptors that are associated with likely detrimental (i.e. CB1) and beneficial (e.g. GPR55, GPR119, PPARs, TRPV1) actions in the context of metabolic diseases.